BACKGROUND: Many studies demonstrate a high rate of treatment-related adverse outcomes or adverse events. No studies have prospectively evaluated adverse events in patients discharged home from the emergency department (ED). OBJECTIVE: To describe the types of adverse events in patients discharged home from an ED. PATIENTS: PATIENTS who were sent home directly from the ED of an urban, academic teaching hospital in Ottawa, Canada. METHODS: Patient records were reviewed to identify demographic and medical history information. Two weeks following the ED visit, patients completed a standard telephone interview to record post ED visit outcomes. Two physicians reviewed outcomes to identify all adverse events and their cause. RESULTS: Follow-up was complete for 399 of 408 enrolled patients. The median age was 49 years (interquartile range 36-68) and 50% were male. The most common diagnosis was "chest pain", occurring in 74 patients (18%), followed by "bone and joint disorders" in 55 patients (14%). 24 patients experienced an adverse event (incidence 6% (95% CI 4% to 9%)), of which 17 were preventable (incidence 4% (95% CI 3% to 7%)). Five of the unpreventable adverse events were medication side effects and two were minor, procedure-related complications. Of all 24 adverse events, 15 (63%; 95% CI 43 to 79%) led to an additional ED visit or a hospitalisation. Preventable adverse events occurred in 5 of 78 chest pain patients (incidence 6% (95% CI 3% to 14%)). CONCLUSION: Most adverse events occurring following an ED visit are preventable and often relate to diagnostic or management errors.
BACKGROUND: Many studies demonstrate a high rate of treatment-related adverse outcomes or adverse events. No studies have prospectively evaluated adverse events in patients discharged home from the emergency department (ED). OBJECTIVE: To describe the types of adverse events in patients discharged home from an ED. PATIENTS: PATIENTS who were sent home directly from the ED of an urban, academic teaching hospital in Ottawa, Canada. METHODS:Patient records were reviewed to identify demographic and medical history information. Two weeks following the ED visit, patients completed a standard telephone interview to record post ED visit outcomes. Two physicians reviewed outcomes to identify all adverse events and their cause. RESULTS: Follow-up was complete for 399 of 408 enrolled patients. The median age was 49 years (interquartile range 36-68) and 50% were male. The most common diagnosis was "chest pain", occurring in 74 patients (18%), followed by "bone and joint disorders" in 55 patients (14%). 24 patients experienced an adverse event (incidence 6% (95% CI 4% to 9%)), of which 17 were preventable (incidence 4% (95% CI 3% to 7%)). Five of the unpreventable adverse events were medication side effects and two were minor, procedure-related complications. Of all 24 adverse events, 15 (63%; 95% CI 43 to 79%) led to an additional ED visit or a hospitalisation. Preventable adverse events occurred in 5 of 78 chest painpatients (incidence 6% (95% CI 3% to 14%)). CONCLUSION: Most adverse events occurring following an ED visit are preventable and often relate to diagnostic or management errors.
Authors: James Fordyce; Fidela S j Blank; Penelope Pekow; Howard A Smithline; George Ritter; Stephen Gehlbach; Evan Benjamin; Philip L Henneman Journal: Ann Emerg Med Date: 2003-09 Impact factor: 5.721
Authors: Richard T Griffey; Nicole Shin; Solita Jones; Nnenna Aginam; Maureen Gross; Yonitte Kinsella; Jennifer A Williams; Christopher R Carpenter; Melody Goodman; Kimberly A Kaphingst Journal: J Commun Healthc Date: 2015-03
Authors: Richard T Griffey; Sarah K Kennedy; Lucy D'Agostino McGowan; Lucy McGownan; Melody Goodman; Kimberly A Kaphingst Journal: Acad Emerg Med Date: 2014-10 Impact factor: 3.451
Authors: Richard Hoang; Kari Sampsel; Andrew Willmore; Katerina Yelle Labre; Venkatesh Thiruganasambandamoorthy; Lisa A Calder Journal: CJEM Date: 2021-09-29 Impact factor: 2.410
Authors: Richard T Griffey; Ryan M Schneider; Brian R Sharp; Jeff Pothof; Marie C Vrablik; Nic Granzella; Alexandre A Todorov; Lee Adler Journal: J Patient Saf Date: 2021-12-01 Impact factor: 2.844